705918 |
FRONTIERS IN GENETICS |
Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma |
2021-06-23 |
10.3389/fgene.2021.661988 |
Chen Xingte, Wang Lei, Hong Liang, Su Zhixiong, Zhong Xiaohong, Zhou Han, Zhang Xueqing, Wu Junxin, Shao Lingdong |
705917 |
FRONTIERS IN ONCOLOGY |
miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma |
2021-06-23 |
10.3389/fonc.2021.634841 |
Xue Weijie, Wang Yixiu, Xie Yuwei, Yang Chenyu, Gong Zhiqi, Guan Chunyang, Wei Chuqing, Zhu Chengzhan, Niu Zhaojian |
705916 |
FRONTIERS IN ONCOLOGY |
CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death |
2021-06-23 |
10.3389/fonc.2021.681683 |
Ding Bisha, Bao Chang, Jin Luqi, Xu Liang, Fan Weimin, Lou Weiyang |
705915 |
FRONTIERS IN ONCOLOGY |
IRAK2, an IL1R/TLR Immune Mediator, Enhances Radiosensitivity via Modulating Caspase 8/3-Mediated Apoptosis in Oral Squamous Cell Carcinoma |
2021-06-23 |
10.3389/fonc.2021.647175 |
Yu Chih-Chia, Chan Michael W.Y., Lin Hon-Yi, Chiou Wen-Yen, Lin Ru-Inn, Chen Chien-An, Lee Moon-Sing, Chi Chen-Lin, Chen Liang-Cheng, Huang Li-Wen, Chew Chia-Hui, Hsu Feng-Chun, Yang Hsuan-Ju, Hung Shih-Kai |
705914 |
FRONTIERS IN ONCOLOGY |
piR-hsa-211106 Inhibits the Progression of Lung Adenocarcinoma Through Pyruvate Carboxylase and Enhances Chemotherapy Sensitivity |
2021-06-23 |
10.3389/fonc.2021.651915 |
Liu Yongmei, Dong Yanhan, He Xinjia, Gong Anjing, Gao Jinning, Hao Xiaodan, Wang Shuai, Fan Yuqiao, Wang Zibo, Li Meng, Xu Wenhua |
705913 |
FRONTIERS IN ONCOLOGY |
TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway |
2021-06-23 |
10.3389/fonc.2021.680985 |
Feng Fang, Liu Chunliang, Bian Huahui, Cai Wei, Zhou Ying, Zhou Li, Zhuang Zhixiang |
705912 |
FRONTIERS IN ONCOLOGY |
Machine-Learning-Derived Nomogram Based on 3D Radiomic Features and Clinical Factors Predicts Progression-Free Survival in Lung Adenocarcinoma |
2021-06-23 |
10.3389/fonc.2021.692329 |
Liu Guixue, Xu Zhihan, Zhang Yaping, Jiang Beibei, Zhang Lu, Wang Lingyun, de Bock Geertruida H., Vliegenthart Rozemarijn, Xie Xueqian |
705911 |
FRONTIERS IN ONCOLOGY |
Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma |
2021-06-23 |
10.3389/fonc.2021.675545 |
Lu Lu, Liu Le-Ping, Zhao Qiang-Qiang, Gui Rong, Zhao Qin-Yu |
705910 |
FRONTIERS IN ONCOLOGY |
The Impact of Preoperative Sarcopenia on Survival Prognosis in Patients Receiving Neoadjuvant Therapy for Esophageal Cancer: A Systematic Review and Meta-Analysis |
2021-06-23 |
10.3389/fonc.2021.619592 |
Jin Sheng-bo, Tian Zi-bin, Ding Xue-li, Guo Ying-jie, Mao Tao, Yu Ya-nan, Wang Kai-xuan, Jing Xue |
705909 |
FRONTIERS IN ONCOLOGY |
Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment |
2021-06-23 |
10.3389/fonc.2021.646338 |
Niu Shaoxi, Liu Kan, Xu Yong, Peng Cheng, Yu Yao, Huang Qingbo, Wu Shengpan, Cui Bo, Huang Yan, Ma Xin, Zhang Xu, Wang Baojun |